NCT07386704 2026-02-04
Nimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic Cancer
Peking University First Hospital
Phase 2 Enrolling by invitation
Clinical Trials
5 trialsNCT07302841 2025-12-24
Tunlametinib + AG + Cetuximab β as First-Line Therapy for Advanced Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 4 Not yet recruiting
NCT07271823 2025-12-09
Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer
Zhejiang Cancer Hospital
Active not recruiting
NCT06605430 2025-07-29
CanPan-C
HealthPartners Institute
Phase 2 Recruiting
NCT06937996 2025-06-17
Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System-
Englewood Hospital and Medical Center
Recruiting